Australian Gold

Product NDC
58443-0072
11-digit product format
584430072
Labeler code
58443
Product ID
58443-0072_9c582eb0-d62b-3048-e053-2995a90adbfd
Type
HUMAN OTC DRUG
Nonproprietary name
Avobenzone, Octisalate and Octocrylene
Dosage form
LOTION
Route
TOPICAL
Labeler
Prime Enterprises, Inc.
Application
part352
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2013-10-31
Marketing end
0000-00-00
Substance
AVOBENZONE; OCTISALATE; OCTOCRYLENE
Active strength
16 mg/mL; mg/mL; mg/mL
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct58443-0072DDiscontinued by firm2026-10-12
excluded packagepackage58443-007258443-0072-4DDiscontinued by firm2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage58443-0072-4d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage58443-0072-4f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage58443-0072-42ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage58443-0072-4a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage58443-0072-4cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage58443-0072-4cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage58443-0072-4302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage58443-0072-4ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage58443-0072-40efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage58443-0072-4ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage58443-0072-4367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage58443-0072-4557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
AVOBENZONEACTIVE INGREDIENTG63QQF2NOXAUSTRALIAN GOLD BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) LOTION [PRIME ENTERPRISES, INC.]1
OCTISALATEACTIVE INGREDIENT4X49Y0596WAUSTRALIAN GOLD BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) LOTION [PRIME ENTERPRISES, INC.]1
OCTOCRYLENEACTIVE INGREDIENT5A68WGF6WMAUSTRALIAN GOLD BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) LOTION [PRIME ENTERPRISES, INC.]1
AVOBENZONEACTIVE MOIETYG63QQF2NOXAUSTRALIAN GOLD BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) LOTION [PRIME ENTERPRISES, INC.]1
OCTISALATEACTIVE MOIETY4X49Y0596WAUSTRALIAN GOLD BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) LOTION [PRIME ENTERPRISES, INC.]1
OCTOCRYLENEACTIVE MOIETY5A68WGF6WMAUSTRALIAN GOLD BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) LOTION [PRIME ENTERPRISES, INC.]1
ALCOHOLINACTIVE INGREDIENT3K9958V90MAUSTRALIAN GOLD BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) LOTION [PRIME ENTERPRISES, INC.]1
DIBUTYL MALEATEINACTIVE INGREDIENT4X371TMK9KAUSTRALIAN GOLD BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) LOTION [PRIME ENTERPRISES, INC.]1
DIETHYLHEXYL 2,6-NAPHTHALATEINACTIVE INGREDIENTI0DQJ7YGXMAUSTRALIAN GOLD BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) LOTION [PRIME ENTERPRISES, INC.]1
FD&C BLUE NO. 1INACTIVE INGREDIENTH3R47K3TBDAUSTRALIAN GOLD BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) LOTION [PRIME ENTERPRISES, INC.]1
FD&C RED NO. 40INACTIVE INGREDIENTWZB9127XOAAUSTRALIAN GOLD BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) LOTION [PRIME ENTERPRISES, INC.]1
FD&C YELLOW NO. 5INACTIVE INGREDIENTI753WB2F1MAUSTRALIAN GOLD BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) LOTION [PRIME ENTERPRISES, INC.]1
GLYCERININACTIVE INGREDIENTPDC6A3C0OXAUSTRALIAN GOLD BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) LOTION [PRIME ENTERPRISES, INC.]1
KAKADU PLUMINACTIVE INGREDIENT0ZQ1D2FDLIAUSTRALIAN GOLD BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) LOTION [PRIME ENTERPRISES, INC.]1
POLYESTER-8 (1400 MW, CYANODIPHENYLPROPENOYL CAPPED)INACTIVE INGREDIENTT9296U138PAUSTRALIAN GOLD BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) LOTION [PRIME ENTERPRISES, INC.]1
WATERINACTIVE INGREDIENT059QF0KO0RAUSTRALIAN GOLD BROAD SPECTRUM SPF 15 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) LOTION [PRIME ENTERPRISES, INC.]1

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
58443-0072-458443007204177 mL in 1 BOTTLE (58443-0072-4) 177 ml2013-10-310000-00-00NoNoCurrent